Search Results 1741-1750 of 17438 for magnesiummagnesium

1. A Study to Evaluate Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration In HPV Head And Neck Cancer - Mayo Clinic

   Creatinine ≤ 1.5 mg/dL or creatinine clearance ≥ 50 mL/min;; Total or direct bilirubin < 2 x institutional upper limit of normal (ULN);; AST (SGOT) or ALT ...

2. A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease - Mayo Clinic

   The primary objective is to evaluate whether macitentan 10 mg reduces N-terminal pro-brain natriuretic peptide (NT-pro-BNP) as compared to placebo in these ...

3. A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients - Mayo Clinic

   Patient has clinically significant renal impairment, defined as creatinine > mg/dL or blood urea nitrogen > 2 × upper limit of normal (ULN); clinically ...

4. Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC) - Mayo Clinic

   Corrected calcium > 10.0 mg/dL; KPS < 80%; Neutrophils > ULN; Platelets > ULN. Planned or elective surgical treatment post-nephrectomy for the direct management ...

5. SYMPHONY: A Study of Macitentan in Pulmonary Arterial Hypertension to Validate the PAH-SYMPACT - Mayo Clinic

   Patients will be in the study for 5 1/2 months, 4 months of which they will receive macitentan, 10 mg, once daily. The primary objectives are to demonstrate ...

6. Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer - Mayo Clinic

   Creatinine less than 1.4 mg/dl; Bilirubin less than or equal to 1.5 x institutional/laboratory upper limit of normal (ULN); Aspartate aminotransferase (AST) ...

7. Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer - Mayo Clinic

   ... mg/dL OR calculated (calc.) creatinine clearance >= 60 mL/min; Bilirubin =< 1.5 x ULN; Aspartate aminotransferase (AST) =< 2.5 x ULN; Although they will not be ...

8. A Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients with Primary Biliary Cirrhosis

   ... mg/dL (178 μmol/L). Have undergone gastric bypass procedures (gastric lap band is acceptable) or ileal resection or plan to undergo either of these ...

9. Study of TJ011133 in Participants With Relapsed/ Refractory Advanced Solid Tumors and Lymphoma - Mayo Clinic

   In Part 1A (45 mg/kg dose cohort only), Part 1B or Part 1C, archival ... mg daily of prednisone equivalent) or any other form of immunosuppressive ...

10. A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients with Recurrent Glioblastoma with Elevated Mutational Burden - Mayo Clinic

    Does not require > 4 mg dexamethasone beyond the perioperative period defined as the time ≤ 2 weeks after surgical procedure. Eastern Cooperative Oncology ...